Skip to main content

Table 3 Laboratory measures

From: Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort

 

T0

T6

Δ T0–T6

 

All patients

N

C

All patients

N

C

All patients

N

C

HB, g/dl, mean ± SD

14.3 ± 1.3

14.3 ± 1.1

14.2 ± 1.4

14.4 ± 1.2

14.4 ± 1.1

14.4 ± 1.3

0.1 ± 0.9

0.1 ± 1

0.1 ± 0.8

WBC, 1/mm3, mean ± SD

6684.6 ± 1809.9

6681.9 ± 1722.3

6731.4 ± 1885

6911.2 ± 1750.7

6649.6 ± 1512.8

7106.3 ± 1897.3

226.5 ± 1505.4

227.7 ± 1347.8

374.9 ± 1607.5

PLT, 103/mm3, mean ± SD

267.5 ± 229.1

241.5 ± 59.2

287 ± 298

247.5 ± 65.2

239.2 ± 60.5

253.6 ± 68.2

−20.1 ± 225.5

−12.3 ± 34.4

−33.4 ± 296.8

CRP, mg/L, mean ± SD

3.4 ± 6.2

3.2 ± 3.9

3.7 ± 7.4

3.5 ± 5.6

2.6 ± 3.1

4.1 ± 6.9

0.1 ± 6.4

−0.1 ± 4

0.3 ± 7.7

ESR, mm/h, mean ± SD

15.2 ± 17.1

13.8 ± 14.4

16.3 ± 18.9

14.1 ± 13.6

11.6 ± 10.3

16 ± 15.5

−1.1 ± 13.1

−2.2 ± 9.7

−0.3 ± 15.2

Urate, mg/dl, mean ± SD

5.5 ± 1.1

5.4 ± 1

5.6 ± 1.3

4.8 ± 1.8

4.7 ± 2

4.9 ± 1.7

−0.5 ± 1.6

−0.1 ± 0.3

−0.7 ± 1.9

HbA1c, mmol/mol, mean ± SD***

47.4 ± 15

52.5 ± 21.1

44 ± 9

59.6 ± 20.7

63.2 ± 26.1

57.7 ± 18.5

4.5 ± 13.3

7.3 ± 21.5

2.7 ± 5.6

FBG, mg/dl, mean ± SD*

105.1 ± 26.5

113.3 ± 30.4

100.9 ± 23.8

101.6 ± 27.2

98.9 ± 25

103.5 ± 28.9

2.4 ± 21.4

−7.4 ± 14.7

7.3 ± 22.9

LDL-c, mg/dl, mean ± SD

130.8 ± 36.5

132.3 ± 35

129.7 ± 38.4

130.6 ± 34.7

125.7 ± 34.8

134.4 ± 34.5

−1.2 ± 24.1

−5.2 ± 31.6

1.8 ± 16.7

HDL-c, mg/dl, mean ± SD**

54.7 ± 15.4

61.1 ± 17.5

49.8 ± 11.7

55.7 ± 17.5

59.2 ± 21.2

53 ± 13.6

0 ± 8

−1.1 ± 7.3

0.9 ± 8.5

TC, mg/dl, mean ± SD

209.7 ± 45.1

211.4 ± 41.2

208.5 ± 48.4

205.6 ± 37.2

204.9 ± 40.6

206.2 ± 34.6

2.1 ± 26

−0.1 ± 29.5

3.8 ± 23.3

Triglycerides, mg/dl, mean ± SD

123.2 ± 63.4

118.8 ± 57.3

127.4 ± 65.7

125.3 ± 57.8

115.5 ± 52.5

130.8 ± 60.6

2.5 ± 44

−3.3 ± 51.1

3.8 ± 38.1

TC/HDL-c ratio, mean ± SD

4 ± 1.4

3.8 ± 1.3

4.2 ± 1.4

4.1 ± 1.4

3.9 ± 1.3

4.3 ± 1.5

0.1 ± 0.5

0 ± 0.6

0.1 ± 0.4

GOT, U/L, mean ± SD

22.4 ± 8.7

23.1 ± 9.1

21.8 ± 8.5

23.1 ± 8.2

23.5 ± 8.6

22.9 ± 8

0.8 ± 8

0.4 ± 7.9

1 ± 8.2

GPT, U/L, mean ± SD

24.4 ± 15

24.7 ± 15.2

24.3 ± 15

25.1 ± 13.6

25.1 ± 12.6

25.1 ± 14.4

0.7 ± 13.1

0.4 ± 11.3

0.9 ± 14.3

GGT, U/L, mean ± SD

21.8 ± 19.1

23.7 ± 20.3

20.5 ± 18.1

23.5 ± 19.7

24.6 ± 23.4

22.7 ± 16.5

1.7 ± 20.2

1 ± 16.6

2.2 ± 22.5

Creatinine, mg/dl, mean ± SD

0.9 ± 0.2

0.9 ± 0.3

0.9 ± 0.2

1 ± 1.4

1.2 ± 2.1

0.8 ± 0.2

0.1 ± 1.3

0.3 ± 2

0 ± 0.1

TSH, μU/ml, mean ± SD

3.2 ± 2

2.9 ± 0.5

3.3 ± 2

3.5 ± 2.6

3.6 ± 3.6

3.4 ± 1.9

0.3w ± 3.7

0.5 ± 6.4

0.2 ± 0.4

  1. N nutritional group, C control group, HB hemoglobin, WBC white blood count, PLT platelets, ESR erythrocyte sedimentation rate, CRP C-reactive protein, HbA1c glycated hemoglobin, FBG fasting blood glucose, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, TC total cholesterol, GOT glutamic oxaloacetic transaminase, GPT glutamic pyruvic transaminase, GGT gamma-glutamyltransferase, TSH thyroid-stimulating hormone
  2. *A significative difference in the FBG levels was observed at T0 comparing the N and C (p = 0.039)
  3. **A significative difference in the HDL-c levels was observed at T0 comparing the N and C (p = 0.048)
  4. ***A significative change in HbA1c was observed at T6 in the N compared to C (p = 0.01)
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us